Recombinant HIV1 Nef protein (Beta-Galactosidase) (ab49060)

製品の概要

法規制情報

製品の詳細

  • 由来Recombinant
  • 由来Escherichia coli
  • アミノ酸配列
    • 配列の追加情報Fused with β-galactosidase at the N-terminus.

特性

Our Abpromise guarantee covers the use of ab49060 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • 生理活性Reacts strongly with human HIV positive serum.
  • アプリケーション

    ELISA

    Western blot

  • 精製度> 95 % SDS-PAGE.

  • 製品の状態Liquid
  • 備考Reacts strongly with human HIV positive serum.
  • Concentration information loading...

前処理および保存

  • 保存方法および安定性

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.

    Preservative: None
    Constituents: 0.014M Beta mercaptoethanol, 0.01M Sodium carbonate, 0.01M EDTA

関連情報

  • 別名
    • C terminal core protein
    • F protein
    • Nef
    • Negative factor
    • p27
    see all
  • 関連性Nef is a early protein that appears to play a role in optimizing the host cell environment for viral replication without causing cell death by apoptosis. Nef enhances virus infectivity and pathogenicity. It down modulates surface MHC I molecules and internalized molecules are sequested to the trans-Golgi network. The number of cell surface CD4 antigen are decreased by interacting with the Src family kinase LCK thereby inducing LCK CD4 dissociation and by increasing clathrin-dependent endocytosis of this antigen to target it to lysosomal degradation.

Recombinant HIV1 Nef protein (Beta-Galactosidase) (ab49060) 使用論文

ab49060 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab49060.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"